This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Type 2 diabetes mellitus

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Type 2 diabetes is a chronic metabolic condition characterised by insulin resistance (that is, the body's inability to effectively use insulin) and insufficient pancreatic insulin production, resulting in high blood glucose levels (hyperglycaemia)

  • Type 2 diabetes is commonly associated with obesity, physical inactivity, raised blood pressure, disturbed blood lipid levels and a tendency to develop thrombosis, and therefore is recognised to have an increased cardiovascular risk
  • is associated with long-term microvascular and macrovascular complications, together with reduced quality of life and life expectancy

In 2013, over 3.2 million adults were diagnosed with diabetes, with prevalence rates of 6% and 6.7% in England and Wales respectively

  • estimated that about 90% of adults currently diagnosed with diabetes have type 2 diabetes
  • Type 2 diabetes is more common in people of African, African-Caribbean and South Asian family origin
  • can occur in all age groups and is increasingly being diagnosed in children

Characteristics (in general):

  • onset often after 40 years of age
  • no HLA associations
  • 58% concordance in identical twins (2)
  • no islet cell antibodies
  • there is insulin resistance
  • glucagon secretion is increased
  • often the patient is obese
  • the patient is not prone to ketoacidosis
  • there is no association with autoimmune disease
  • more common in people of African, African-Caribbean and South Asian family origin

Treatment:

  • nutritional therapy
  • oral hypoglycaemic agents
  • occasionally insulin therapy

lifetime risk of type 2 diabetes

  • study evidence found type 2 diabetes lifetime risk ranged from 16.3% (95% CI 15.6-17.0) for Scottish women to 59.6% (58.5-60.8) for Singaporean men (3)

Reference:

  1. NICE (December 2015). Type 2 diabetes in adults: management
  2. Newman B et al.Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987;30:763-8
  3. Tomic D et al. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet - Diabetes and Endocrinology September 29th 2022.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.